Distinct component profiles and high risk among african americans with metabolic syndrome

Diabetes Care

Volumn 31, Issue 6, 2008, Pages 1248-1253

  Taylor, Herman ^a,b   Liu, Jiankang ^a   Wilson, Gregory ^a   Golden, Sherita H ^a   Crook, Errol ^a   Brunson, Claude D ^a   Steffes, Micheal ^a   Johnson, William D ^a   Sung, Jung Hye ^a  

^a JACKSON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ABDOMINAL OBESITY; ADULT; AFRICAN AMERICAN; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; SMOKING; SOCIAL STATUS; BLOOD; CORONARY ARTERY DISEASE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MIDDLE AGED; NEGRO; OBESITY; RISK; RISK FACTOR; STATISTICS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; DIABETES MELLITUS; HUMANS; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; PREVALENCE; RISK FACTORS;

EID: 48649102187     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1810     Document Type: Article

References (36)

1. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Stein- berger J, Wasserthiel-Smoller S, Wilson M, Wolf P: Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85-e151, 2006
2. Ferdinand KC: Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol 97:12A-19A, 2006
3. Sempos C, Cooper R, Kovar MG, Mc- Millen M: Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States. Am J Public Health 78:1422-1427, 1988
4. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA: Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Indian Heart J 52:S35-S43, 2000
5. Winkleby MA, Kraemer HC, Ahn DK, Varady AN: Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 280:356-362, 1998
6. Lorenzo C, Williams K, Hunt KJ, Haffner SM: Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care 29: 625-630, 2006
7. Lakka HM, Laaksonen DE, Lakka TA, Ni- skanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709 - 2716, 2002
8. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689, 2001
9. Ford ES: The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173: 309-314, 2004
10. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24:e13-e18, 2004
11. Ford ES: Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 33:333-350, 2004
12. Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52:2160-2167, 2003
13. Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165: 2644-2650, 2005
14. Taylor HA Jr, Wilson JG, Jones DW, Sarpong DF, Srinivasan A, Garrison RJ, Nelson C, Wyatt SB: Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. EthnDis 15:S6-S17, 2005
15. Fuqua SR, Wyatt SB, Andrew ME, Sar- pong DF, Henderson FR, Cunningham MF, Taylor HA Jr: Recruiting African- American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis 15:S6 -S29, 2005
16. Wilson JG, Rotimi CN, Ekunwe L, Royal CD, Crump ME, Wyatt SB, Steffes MW, Adeyemo A, Zhou J, Taylor HA Jr, Jaquish C: Study design for genetic analysis in the Jackson Heart Study. EthnDis 15:S6-S37, 2005
17. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballan- tyne CM, Heiss G: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28:385-390, 2005
18. Ford ES, Giles WH, Mokdad AH: Increas ing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 27: 2444-2449, 2004
19. Morrison JA, Friedman LA, Harlan WR, Harlan LC, Barton BA, Schreiber GB, Klein DJ: Development of the metabolic syndrome in black and white adolescent girls: a longitudinal assessment. Pediatrics 116:1178-1182, 2005
20. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB: The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163: 427-436, 2003
21. Ford ES, Giles WH: A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26:575-581, 2003
22. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K: Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CAR- DIA) study, 1985-2001. Diabetes Care 27:2707-2715, 2004
23. McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE, Ballantyne C: Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (the ARIC Study). Am J Cardiol 94: 1249 -1254, 2004
24. Cook CB, Erdman DM, Ryan GJ, Green- lund KJ, Giles WH, Gallina DL, El-Kebbi IM, Ziemer DC, Ernst KL, Dunbar VG, Phillips LS: The pattern of dyslipidemia among urban African-Americans with type 2 diabetes. Diabetes Care 23:319 - 324, 2000
25. Jacobs MJ, Kleisli T, Pio JR, Malik S, L'Italien GJ, Chen RS, Wong ND: Prevalence and control of dyslipidemia among persons with diabetes in the United States. Diabetes Res Clin Pract 70:263-269, 2005
26. Sumner AE, Vega GL, Genovese DJ, Fin- ley KB, Bergman RN, Boston RC: Normal triglyceride levels despite insulin resistance in African Americans: role of li- poprotein lipase. Metabolism 54:902-909, 2005
27. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289-2304, 2005
28. Patel A, Huang KC, Janus ED, Gill T, Neal B, Suriyawongpaisal P, Wong E, Woodward M, Stolk RP: Is a single definition of the metabolic syndrome appropriate?-A comparative study of the USA and Asia. Atherosclerosis 184:225-232, 2006
29. GoldenSH, FolsomAR, CoreshJ, Sharrett AR, Szklo M, Brancati F: Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis. Diabetes 51:3069-3076, 2002
30. Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, Falces C, Serrano-Rios M, Gabriel R, Shaw JE, Zimmet PZ, Haffner S: A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 29:113-122, 2006
31. Appel SJ: Calculating insulin resistance in the primary care setting: why should we worry about insulin levels in euglycemic patients? J Am Acad Nurse Pract 17:331-336, 2005
32. Jones DW, Chambless LE, Folsom AR, Heiss G, Hutchinson RG, Sharrett AR, Szklo M, Taylor HA Jr: Risk factors for coronary heart disease in African Americans: 1987-1997. Arch Intern Med 162: 2565-2571, 2002
33. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP: National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110:1251-1257, 2004
34. Lonnqvist F, Thorne A, Large V, Arner P: Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arte- rioscler Thromb Vasc Biol 17:1472-1480, 1997
35. Haffner SM, D'Agostino R, Saad MF, Rewers M, Mykkanen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, et al.: Increased insulin resistance and insulin secretion in nondiabetic African- Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes 45: 742-748, 1996
36. Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, Klein RL, Garvey WT: Critical evaluation ofadult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 27:978 -983, 2004